Awarded
Polyvalente hooggeconcentreerde immunoglobulinen (humaan plasma) voor intraveneuze toediening
Original language: Dutch
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- Hospilim VZW
- Winners
- CSL BEHRING, DEPARTEMENT CENTRAL DE FRACTIONNEMENT, Prothya Biosolutions Netherlands B.V., TAKEDA BELGIUM
- Contract value
- €128,334,002
- Bids received
- 4
- Published
- 3 Nov 2026
- Awarded
- 9 Oct 2026
- Contract start
- 18 Oct 2026
- Contract end
- 4 Nov 2027estimated
- Region
- Arr. Hasselt
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Protrombinecomplexconcentraat | Hospilim VZW | OCTAPHARMA BENELUX, Prothya Biosolutions Netherlands B.V. | €856,200 | 3 Nov 2026 |
| Polyvalente hooggeconcentreerde immunoglobulinen (humaan plasma) met een laag IgA-gehalte voor intraveneuze toediening | Hospilim VZW | DEPARTEMENT CENTRAL DE FRACTIONNEMENT, Prothya Biosolutions Netherlands B.V. | €205,000 | 3 Nov 2026 |
| Fibrinogeen | Hospilim VZW | OCTAPHARMA BENELUX | €654,500 | 3 Nov 2026 |
| Tocilizumab | Hospilim VZW | Celltrion Healthcare Netherlands B.V. | — | 30 Oct 2026 |
| Irinotecan IV | Hospilim VZW | ACCORD HEALTHCARE, Fresenius Kabi | €306,042 | 17 Sept 2026 |
| Etoposide IV | Hospilim VZW | ACCORD HEALTHCARE | €19,444 | 17 Sept 2026 |